Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in patients taking the drug. The drug – which is in the same class as Sanofi's ...

Despite what the Detroit-based automakers will tell you, there remains a market for small and mid-sized cars. While the likes of the Focus, Impala, and Dart have been given a one-way ticket to death’s ...

The compact and subcompact crossover segments are perpetually red hot, occupied by dozens of competitors fiercely vying for the attention of customers. Mazda’s entries in these fields are the CX-3 and ...